ENS@T - Revision history

Waza: Remove missing top templates

2026-10-01T03:36:16Z

Remove missing top templates

← Older revision		Revision as of 03:36, 1 October 2026
Line 1:		Line 1:
	~~{{Multiple issues\|~~
	~~{{Notability\|date=November 2025}}~~
	~~{{Primary sources\|date=November 2025}}~~
	~~{{Orphan\|date=December 2025}}~~
	}}
	~~{{infobox organization~~
	~~\|name = ENS@T~~
	~~\|image =~~
	~~\|caption =~~
	~~\|leader_name = Cristina Ronchi~~
	~~\|leader_title = President~~
	~~\|formation = May 15th, 2009~~
	~~\|focus = Permanent and Integrated European Network for Adrenal Tumor Research<ref name="ENSAT Focus">ENS@T by-laws, [https://www.ensat.org/page-1317318], retrieved November 1st, 2025.</ref>~~
	~~\|num_members = 428~~
	~~\|location = {{flagicon\|FR}} [[Paris]], [[France]]~~

	\|
	~~\|website = https://www.ensat.org/~~
	}}

	'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].		'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].

Waza: remove deletion notice

2026-09-30T21:49:18Z

remove deletion notice

← Older revision		Revision as of 21:49, 30 September 2026
Line 1:		Line 1:
	~~<!-- Please do not remove or change this AfD message until the discussion has been closed. -->~~

	~~<!-- Once discussion is closed, please place on talk page: {{Old AfD multi\|page=ENS@T\|date=25 September 2026\|result='''keep'''}} -->~~
	~~<!-- End of AfD message, feel free to edit beyond this point -->~~
	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}

Waza: remove deletion notice

2026-09-30T21:47:12Z

remove deletion notice

← Older revision		Revision as of 21:47, 30 September 2026
Line 1:		Line 1:
	<!-- Please do not remove or change this AfD message until the discussion has been closed. -->		<!-- Please do not remove or change this AfD message until the discussion has been closed. -->
	~~{{Article for deletion/dated\|page=ENS@T\|timestamp=20260925235338\|year=2026\|month=September\|day=25\|substed=yes\|help=off\|outcome=merging\|target=Adrenocortical carcinoma}}~~
	<!-- Once discussion is closed, please place on talk page: {{Old AfD multi\|page=ENS@T\|date=25 September 2026\|result='''keep'''}} -->		<!-- Once discussion is closed, please place on talk page: {{Old AfD multi\|page=ENS@T\|date=25 September 2026\|result='''keep'''}} -->
	<!-- End of AfD message, feel free to edit beyond this point -->		<!-- End of AfD message, feel free to edit beyond this point -->

Waza: 16 revisions imported: Import with full history

2026-09-30T21:44:52Z

16 revisions imported: Import with full history

← Older revision	Revision as of 21:44, 30 September 2026
(No difference)

wikipedia>NNK-Gerald: Several weblinks added

2026-09-26T14:30:00Z

Several weblinks added

← Older revision		Revision as of 14:30, 26 September 2026
Line 53:		Line 53:
	* https://www.endokrinologie.net/sektion-nebenniere-steroide-hypertonie-1.php – Deutsche Gesellschaft für Endokrinologie - Sektion Nebenniere, Steroide und Hypertonie - ENS@T-Initiative (engl. German Society for Endocrinology - Section Adrenal Gland, Steroids and Hypertension - ENS@T Initiative)		* https://www.endokrinologie.net/sektion-nebenniere-steroide-hypertonie-1.php – Deutsche Gesellschaft für Endokrinologie - Sektion Nebenniere, Steroide und Hypertonie - ENS@T-Initiative (engl. German Society for Endocrinology - Section Adrenal Gland, Steroids and Hypertension - ENS@T Initiative)
	* https://www.esmo.org/ ESMO ([[European Society for Medical Oncology]])		* https://www.esmo.org/ ESMO ([[European Society for Medical Oncology]])
			* [https://www.youtube.com/watch?v=Vjwt7vJAFqI Current and future therapeutic strategies for metastatic ACC (][[adrenocortical carcinoma\|AdrenoCortical Carcinoma]]s) (Video with Univ.-Prof. Dr. med. [[Martin Fassnacht]], University Clinic, Wuerzburg)
			* [https://www.youtube.com/watch?v=bvVXJnSc_qc Application of mitotane therapy in ACC,] [https://www.youtube.com/watch?v=Vjwt7vJAFqI AdrenoCortical Carcinomas] (Video with Prof. [[Massimo Terzolo]], University of Turin)
			* [https://academic.oup.com/ejendo/article/189/1/G1/7198474 European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors] (European Journal of Endocrinology, Volume 189, Issue 1, July 2023, Pages G1–G42)
			* [https://pubmed.ncbi.nlm.nih.gov/30299884/ European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors] (European Journal of Endocrinology. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.)
			* [https://endo-ern.eu/rare-adrenal-conditions/existing-networks/ ERN / Endo ERN Existing networks or registries and biobanks] (Adrenal (MTG1) / Existing networks)
			* [https://www.ese-hormones.org/publications/directory/ese-clinical-practice-guideline-on-the-management-of-adrenal-incidentalomas-in-collaboration-with-the-european-network-for-the-study-of-adrenal-tumors/ European Society of Endocrinology Clinical Practice Guideline on the management of Adrenal Incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors] (ESE Clinical Practice Guideline on the management of Adrenal Incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors)
			* [https://academic.oup.com/bjs/article/104/4/358/6123201? European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma] (BJS, Volume 104, Issue 4, March 2017, Pages 358–376)
			* [https://pubmed.ncbi.nlm.nih.gov/33166271/ ENSAT registry-based randomized clinical trials for adrenocortical carcinoma] (Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.)

	== References ==		== References ==

wikipedia>Klbrain: Nominated for merging; see :Wikipedia:Articles for deletion/ENS@T.

2026-09-25T23:53:38Z

Nominated for merging; see Wikipedia:Articles for deletion/ENS@T.

← Older revision		Revision as of 23:53, 25 September 2026
Line 1:		Line 1:
			<!-- Please do not remove or change this AfD message until the discussion has been closed. -->
			{{Article for deletion/dated\|page=ENS@T\|timestamp=20260925235338\|year=2026\|month=September\|day=25\|substed=yes\|help=off\|outcome=merging\|target=Adrenocortical carcinoma}}
			<!-- Once discussion is closed, please place on talk page: {{Old AfD multi\|page=ENS@T\|date=25 September 2026\|result='''keep'''}} -->
			<!-- End of AfD message, feel free to edit beyond this point -->
	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}

wikipedia>Klbrain: Prod contested by NNK-Gerald

2026-09-25T23:46:34Z

Prod contested by NNK-Gerald

← Older revision		Revision as of 23:46, 25 September 2026
Line 1:		Line 1:
	~~{{Proposed deletion/dated~~
	\|concern = Research collaborative networks are rarely notable unless impact is high; that doesn't seem to be the case here. Excessive reliance on primary sources with insufficient evidence of notability. It has been tagged for notability for 9 months with little improvement. It is a translation from the German article, but we can make different decisions here.
	~~\|timestamp = 20260922191911~~
	~~\|nom = Klbrain~~
	~~\|help =~~
	}}
	~~{{Prod2\|Poorly sourced stub about a research project.}}~~
	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}

wikipedia>Bearian: /* */ Prod 2

2026-09-23T17:44:23Z

: Prod 2

← Older revision		Revision as of 17:44, 23 September 2026
Line 5:		Line 5:
	\|help =		\|help =
	}}		}}
			{{Prod2\|Poorly sourced stub about a research project.}}
	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}

wikipedia>Klbrain: Nominated page for deletion using Page Curation (prod)

2026-09-22T19:19:11Z

Nominated page for deletion using Page Curation (prod)

← Older revision		Revision as of 19:19, 22 September 2026
Line 1:		Line 1:
			{{Proposed deletion/dated
			\|concern = Research collaborative networks are rarely notable unless impact is high; that doesn't seem to be the case here. Excessive reliance on primary sources with insufficient evidence of notability. It has been tagged for notability for 9 months with little improvement. It is a translation from the German article, but we can make different decisions here.
			\|timestamp = 20260922191911
			\|nom = Klbrain
			\|help =
			}}

	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}

wikipedia>Zackmann08: fixing infobox and removing deprecated parameters; Cleaning up syntax using indent.js

2026-04-19T15:49:05Z

fixing infobox and removing deprecated parameters; Cleaning up syntax using indent.js

← Older revision		Revision as of 15:49, 19 April 2026
Line 12:		Line 12:
	\|formation = May 15th, 2009		\|formation = May 15th, 2009
	\|focus = Permanent and Integrated European Network for Adrenal Tumor Research<ref name="ENSAT Focus">ENS@T by-laws, [https://www.ensat.org/page-1317318], retrieved November 1st, 2025.</ref>		\|focus = Permanent and Integrated European Network for Adrenal Tumor Research<ref name="ENSAT Focus">ENS@T by-laws, [https://www.ensat.org/page-1317318], retrieved November 1st, 2025.</ref>
	\|~~members~~ = 428		\|num_members = 428
	\|location = {{flagicon\|FR}} [[Paris]], [[France]] \|		\|location = {{flagicon\|FR}} [[Paris]], [[France]]
	\|website = https://www.ensat.org/}}
			\|
			\|website = https://www.ensat.org/
			}}

	'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].		'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].

← Older revision		Revision as of 03:36, 1 October 2026
Line 1:		Line 1:
	~~{{Multiple issues\|~~
	~~{{Notability\|date=November 2025}}~~
	~~{{Primary sources\|date=November 2025}}~~
	~~{{Orphan\|date=December 2025}}~~
	}}
	~~{{infobox organization~~
	~~\|name = ENS@T~~
	~~\|image =~~
	~~\|caption =~~
	~~\|leader_name = Cristina Ronchi~~
	~~\|leader_title = President~~
	~~\|formation = May 15th, 2009~~
	~~\|focus = Permanent and Integrated European Network for Adrenal Tumor Research<ref name="ENSAT Focus">ENS@T by-laws, [https://www.ensat.org/page-1317318], retrieved November 1st, 2025.</ref>~~
	~~\|num_members = 428~~
	~~\|location = {{flagicon\|FR}} [[Paris]], [[France]]~~

	\|
	~~\|website = https://www.ensat.org/~~
	}}

	'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].		'''European Network for the Study of Adrenal Tumors – ENS@T''' was founded in 2009 to promote research on adrenal tumors. Its target is to improve the understanding of the [[pathophysiology]] and natural progression, as well as the [[diagnostic]] and [[therapeutic]] treatment of [[adrenal tumor]]s and [[adrenal hormone excess]].

← Older revision		Revision as of 23:46, 25 September 2026
Line 1:		Line 1:
	~~{{Proposed deletion/dated~~
	\|concern = Research collaborative networks are rarely notable unless impact is high; that doesn't seem to be the case here. Excessive reliance on primary sources with insufficient evidence of notability. It has been tagged for notability for 9 months with little improvement. It is a translation from the German article, but we can make different decisions here.
	~~\|timestamp = 20260922191911~~
	~~\|nom = Klbrain~~
	~~\|help =~~
	}}
	~~{{Prod2\|Poorly sourced stub about a research project.}}~~
	{{Multiple issues\|		{{Multiple issues\|
	{{Notability\|date=November 2025}}		{{Notability\|date=November 2025}}